🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To see the safety and efficacy of injecting MG4101 as a secondary treatment...
Status
Completed
Location
Samsung Medical Center
Start Date
2014-08
Trial ID
NCT02008929
Treatments Being Tested
This study on manufacture of MG4101 (allogeneic natural killer cell) to use...
Status
Completed
Location
Seoul National University Hospital
Start Date
2016-03-28
Trial ID
NCT02716571
Treatments Being Tested
Phase II study of rituximab plus MG4101 in patients with relapsed or refrac...
Status
Terminated
Location
Seoul National University Hospital
Start Date
2018-11-08
Trial ID
NCT03578198
Treatments Being Tested
To determine the efficacy and safety of combined therapy of determined MG41...
Status
Unknown
Location
Asan Medical Center
Start Date
2018-11-28
Trial ID
NCT03778619
Treatments Being Tested
This study is a single center, single arm, open-labeled phase 2 clinical st...
Status
Completed
Location
Seoul National University Hospital
Start Date
2017-11-01
Trial ID
NCT03349502
Treatments Being Tested
The propose of this study is evaluate the safety and efficacy of MG4101 (al...
Status
Completed
Location
Seoul National University Hospital
Start Date
2016-11-28
Trial ID
NCT02854839
Treatments Being Tested